Daiichi Sankyo launches silodosin for the treatment of dysuria in China
22 April 2013 | By Daiichi Sankyo
Daiichi Sankyo announced that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd., has begun marketing silodosin...
List view / Grid view
22 April 2013 | By Daiichi Sankyo
Daiichi Sankyo announced that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd., has begun marketing silodosin...
8 April 2013 | By Daiichi Sankyo
GHIT Fund aims to promote the R&D of new medicines, vaccines & diagnostics in Japan...
25 March 2013 | By Daiichi Sankyo
Approval to manufacture and market the osteoporosis treatment...
16 March 2013 | By Daiichi Sankyo
Results of the PRASFIT-ACS study...
4 March 2013 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced the following organizational changes taking place from April 1, 2013...
20 February 2013 | By Daiichi Sankyo
DPT-IPV vaccine for prevention of Diphtheria, Pertussis, Tetanus, and acute Poliomyelitis...
14 February 2013 | By Daiichi Sankyo
Daiichi Sankyo will establish a new company, Orphan Disease Treatment Institute Co., Ltd...
16 January 2013 | By Daiichi Sankyo
Daiichi Sankyo and Ranbaxy announced their intention to integrate their business operations in Thailand...
15 January 2013 | By Daiichi Sankyo
“We are encouraged by these findings..."
8 January 2013 | By Daiichi Sankyo
Daiichi Sankyo & Amplimmune have entered into a broad strategic collaboration...
25 October 2012 | By Daiichi Sankyo
Edoxaban is an investigational, once daily, novel oral factor Xa inhibitor...
21 September 2012 | By Daiichi Sankyo
Data from the PRASFIT-ACS study...
26 August 2012 | By Eli Lilly and Company
Study did not meet primary objective of demonstrating prasugrel superiority over clopidogrel in this patient population...
22 August 2012 | By Daiichi Sankyo
Inavir® Dry Powder Inhaler significantly reduces the incidence of influenza infection...
12 July 2012 | By Daiichi Sankyo
Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry’s production facility building grant...